ITI (523610) Q1 24/25 earnings summary
Event summary combining transcript, slides, and related documents.
Q1 24/25 earnings summary
24 Nov, 2025Executive summary
Unaudited standalone and consolidated financial results for the quarter ended June 30, 2024, were approved by the Board on August 12, 2024, following Audit Committee recommendations.
The company continues to operate under a government-approved revival plan, with significant financial assistance received and ongoing support from the Government of India.
The company is executing major defense and telecom projects, including the ASCON Phase IV project for the Ministry of Defence.
Financial highlights
Standalone revenue from operations for Q1 FY25 was ₹51,998 lakhs, with total revenue at ₹53,502 lakhs, down from ₹61,055 lakhs in the previous quarter.
Standalone net loss for the quarter was ₹9,108 lakhs, compared to a net loss of ₹23,894 lakhs in the previous quarter and ₹10,260 lakhs in Q1 FY24.
Consolidated net loss for the quarter was ₹9,131 lakhs, compared to ₹23,882 lakhs in the previous quarter and ₹10,281 lakhs in Q1 FY24.
Basic and diluted EPS for the quarter stood at (₹0.95) on both standalone and consolidated basis.
Total comprehensive loss for the quarter was ₹9,638 lakhs (standalone) and ₹9,661 lakhs (consolidated).
Outlook and guidance
Management maintains a going concern basis, citing a high-value order book of ₹11,252 crores under execution and expected conversion of ₹1,814.86 crores of unbilled revenue within 12 months.
The ASCON Phase IV project is expected to complete PoC by September 30, 2024, with the overall timeline revised to December 2025.
Latest events from ITI
- Ongoing losses, audit disclaimer, and reliance on government support amid operational risks.523610
Q3 202613 Feb 2026 - Q2 FY26 saw continued losses and auditor disclaimers amid unresolved financial uncertainties.523610
Q2 25/2613 Nov 2025 - Revenue up, losses persist, and auditors issue disclaimer amid major uncertainties.523610
Q2 24/2529 Aug 2025 - Net loss of ₹33,007 lakhs for nine months ended Dec 2024 amid auditor disclaimer and revival plan.523610
Q3 24/2529 Aug 2025 - Significant revenue growth offset by persistent losses and major audit concerns in FY25.523610
Q4 24/2529 Aug 2025 - Q1 FY26 saw continued losses, high expenses, and auditor disclaimer amid compliance and receivable issues.523610
Q1 25/2629 Aug 2025